13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Nuclear magnetic resonance structure revealed that the human polyomavirus JC virus agnoprotein contains an α-helix encompassing the Leu/Ile/Phe-rich domain.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Agnoprotein is a small multifunctional regulatory protein required for sustaining the productive replication of JC virus (JCV). It is a mostly cytoplasmic protein localizing in the perinuclear area and forms highly stable dimers/oligomers through a Leu/Ile/Phe-rich domain. There have been no three-dimensional structural data available for agnoprotein due to difficulties associated with the dynamic conversion from monomers to oligomers. Here, we report the first nuclear magnetic resonance (NMR) structure of a synthetic agnoprotein peptide spanning amino acids Thr17 to Glu55 where Lys23 to Phe39 encompassing the Leu/Ile/Phe-rich domain forms an amphipathic α-helix. On the basis of these structural data, a number of Ala substitution mutations were made to investigate the role of the α-helix in the structure and function of agnoprotein. Single L29A and L36A mutations exhibited a significant negative effect on both protein stability and viral replication, whereas the L32A mutation did not. In addition, the L29A mutant displayed a highly nuclear localization pattern, in contrast to the pattern for the wild type (WT). Interestingly, a triple mutant, the L29A+L32A+L36A mutant, yielded no detectable agnoprotein expression, and the replication of this JCV mutant was significantly reduced, suggesting that Leu29 and Leu36 are located at the dimer interface, contributing to the structure and stability of agnoprotein. Two other single mutations, L33A and E34A, did not perturb agnoprotein stability as drastically as that observed with the L29A and L36A mutations, but they negatively affected viral replication, suggesting that the role of these residues is functional rather than structural. Thus, the agnoprotein dimerization domain can be targeted for the development of novel drugs active against JCV infection.

          Related collections

          Author and article information

          Journal
          J. Virol.
          Journal of virology
          1098-5514
          0022-538X
          Jun 2014
          : 88
          : 12
          Affiliations
          [1 ] Université Paris Descartes, Sorbonne Paris Cité, Laboratoire de Cristallographie et RMN Biologiques, UMR 8015 CNRS, Paris, France.
          [2 ] Department of Neuroscience, Laboratory of Molecular Neurovirology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
          [3 ] Temple University School of Pharmacy, Moulder Center for Drug Discovery Research, Philadelphia, Pennsylvania, USA.
          [4 ] Université Paris Descartes, Sorbonne Paris Cité, Laboratoire de Cristallographie et RMN Biologiques, UMR 8015 CNRS, Paris, France serge.bouaziz@parisdescartes.fr msafak@temple.edu.
          [5 ] Department of Neuroscience, Laboratory of Molecular Neurovirology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA serge.bouaziz@parisdescartes.fr msafak@temple.edu.
          Article
          JVI.00146-14
          10.1128/JVI.00146-14
          24672035
          4f8978c5-f53d-43f2-a3eb-92073d63ea9a
          Copyright © 2014, American Society for Microbiology. All Rights Reserved.
          History

          Comments

          Comment on this article